📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

The antimicrobial peptide cathelicidin is critical for the development of Th17 responses in severe inflammatory disease (2022)

First Author: Smith K

Attributed to: Do adult human oligodendrocytes remyelinate poorly and can we change this to better treat progressive multiple sclerosis? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.27.477976

Publication URI: http://dx.doi.org/10.1101/2022.01.27.477976

Type: Preprint